Clinical trial
The Effect of Saxagliptin on Glucose Fluctuation and Immune Regulation in Patients With Type 1 Diabetes
NCT02307695 is registered in ClinicalTrials.gov with Nanjing Medical University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Effect of Saxagliptin on Glucose Fluctuation and Immune Regulation in Patients With Type 1 Diabetes
- Lead sponsor
- Nanjing Medical University
- Phase
- Phase 4
- Overall status
- Unknown status
- Start date
- November 30, 2014
- Completion date
- March 31, 2017
- Enrollment
- 184 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
type 1 diabetes